NFE2L2 and hepatocellular carcinoma: Thus, Shimizu and coworkers reported that phosphorylated p62 was accumulated in HCC (in about 40% of patients) and nuclear localization of NRF2 was frequently observed (63% of HCCs); furthermore, p62 phosphorylation was positively associated with NRF2 activation [171].